Skip to main content
. 2020 Jun 9;38(28):4476–4483. doi: 10.1016/j.vaccine.2019.09.074

Table 4.

Summary of proportion of Solicited AEs.

Vi-DT Group
Placebo Group
Within 7 days after first dose N Number of participants (%) 95% CI N Number of participants (%) 95% CI P-value
All ages 228 59 (25.88%) (20.63, 31.93) 57 11 (19.30%) (11.13, 31.34) 0.295
6 to < 9 month 76 17 (22.37%) (14.46, 32.93) 19 4 (21.05%) (8.51, 43.33)
9 to 12 months 76 29 (38.16%) (28.06, 49.40) 19 5 (26.32%) (11.81 , 48.79)
13 to 23 months 76 13 (17.11%) (10.28, 27.10) 19 2 (10.53%) (2.94 , 31.39)